Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 28, 2015
Increased expression of interleukin-8 is an independent indicator of poor prognosis in clear-cell renal cell carcinomaHuimin An, Yu Zhu, Huyang Xie, et al.
Oncotarget|November 3, 2016
High NUCB2 expression level represents an independent negative prognostic factor in Chinese cohorts of non-metastatic clear cell renal cell carcinoma patientsHangcheng Fu, Yu Zhu, Yiwei Wang, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 25, 2017
Beta-1,4-galactosyltransferase II predicts poor prognosis of patients with non-metastatic clear-cell renal cell carcinomaHaijian Zhang, Yidong Liu, Huyang Xie, et al.
Annals of Surgical Oncology|November 30, 2016
Tumor Infiltrating Mast Cells (TIMs) Confers a Marked Survival Advantage in Nonmetastatic Clear-Cell Renal Cell CarcinomaHangcheng Fu, Yu Zhu, Yiwei Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2018
Identification and Validation of Stromal Immunotype Predict Survival and Benefit from Adjuvant Chemotherapy in Patients with Muscle-Invasive Bladder CancerHangcheng Fu, Yu Zhu, Yiwei Wang, et al.
Oncotarget|April 20, 2016
Increased B4GALT1 expression associates with adverse outcome in patients with non-metastatic clear cell renal cell carcinomaHuyang Xie, Yu Zhu, Huimin An, et al.
Annals of Surgical Oncology|November 9, 2017
Prognostic and Predictive Value of O<sup>6</sup>-methylguanine Methyltransferase for Chemotherapy in Patients with Muscle-Invasive Bladder CancerJunyu Zhang, Yu Zhu, Yiwei Wang, et al.
Oncoimmunology|November 6, 2018
Tumor stroma-infiltrating mast cells predict prognosis and adjuvant chemotherapeutic benefits in patients with muscle invasive bladder cancerZheng Liu, Yu Zhu, Le Xu, et al.
Frontiers in Oncology|September 26, 2019
Development and External Validation of a Novel 12-Gene Signature for Prediction of Overall Survival in Muscle-Invasive Bladder CancerMierXiati Abudurexiti, Huyang Xie, Zhongwei Jia, et al.
BMC Cancer|May 26, 2018
B4GALT1 expression predicts prognosis and adjuvant chemotherapy benefits in muscle-invasive bladder cancer patientsHuyang Xie, Yu Zhu, Junyu Zhang, et al.
Pageof 3